Hacker News new | ask | show | jobs
by pindab0ter 504 days ago
Reading the article, it doesn't seem so.

The drug looks promising, even though it will probably not work in all cases.

1 comments

I disagree. This article is typical embellishment from the university that produced the research. The reality is that they're likely pre-trial stage. Even if they make it through all stages of clinical trials (historically, chances of a drug candidate doing that are 2-5%), that usually takes the better part of a decade. So the answer is "no, we're very far from curing it".
They're at phase 2a trial stage, study start was at 2024-06-05, completion estimated 2025-12:

https://clinicaltrials.gov/study/NCT06393452?term=pp405&rank...